Loading Events
10/2/2027 - 22/9/2027

Horizon Europe. Cluster 1: Health 2027

Project Manager: Cristina Marcos opi@ibsal.es
Scope: International
Type: Public
Area: Research Project
Funding Agency: European Commission Horizon Europe
Funding: 6–8 million / Project
Submission Deadline: February 10, 2027, to September 22, 2027

Share in:

Features

The work program for Cluster 1 (Health) under Horizon Europe has been published: Horizon Europe Cluster 1 Health Work Program for 2027. It falls within the framework of the new Horizon Europe strategic plan for the 2025–2027 period. The main priorities focus on social cohesion, inclusion, and the overall health and well-being of Europeans, in line with the European Pillar of Social Rights. Other key priorities include the need to modernize health care systems and to support an innovative, sustainable, and competitive health industry in Europe.

More specifically, Cluster 1 strives to contribute to six expected impacts as set forth in the Strategic Plan, which are distributed across the following topics:

List of calls for applications that open on February 10, 2027, and close on April 13, 2027:

Destination – Staying Healthy in a Rapidly Changing Society

HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing Disabilities Throughout the Life Course to Support Independent Living and Inclusion

Destination – Living and Working in a Health-Promoting Environment

HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterizing its changes in response to climate change

HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change

Destination – Tackling Diseases and Reducing the Disease Burden

HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small-molecule antiviral therapeutics for pathogens with epidemic potential

HORIZON-HLTH-2027-01-DISEASE-06: Development of Monoclonal Antibodies to Prevent and Treat Infections Caused by Flaviviruses

HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections caused by Filo-, Nairo-, Phenui-, Picorna-, and Toga viruses

HORIZON-HLTH-2027-01-DISEASE-08: Development of Innovative Antimicrobials Against Antimicrobial-Resistant Pathogens

HORIZON-HLTH-2027-01-DISEASE-10: Prevention and Management of Chronic Noncommunicable Diseases in Children and Young People (GACD)

Destination – Ensuring equal access to innovative, sustainable, and high-quality healthcare

HORIZON-HLTH-2027-01-CARE-02: Personalized Approaches to Reduce Risks from Adverse Drug Reactions Resulting from the Administration of Multiple Medications

Destination – Maintaining an innovative, sustainable, and competitive EU healthcare industry

HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for the discovery and/or production of biologics

 

List of two-phase calls for proposals opening on February 10, 2027. The first phase closes on April 13, 2027, and the second phase closes on September 22, 2027:

Destination – Tackling Diseases and Reducing the Disease Burden

HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for noncommunicable diseases

HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials to advance innovative interventions for neurodegenerative diseases

Destination – Developing and using new tools, technologies, and digital solutions for a healthy society

HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers for disease progression and treatment response using AI methodologies for chronic noncommunicable diseases

Destination – Maintaining an innovative, sustainable, and competitive EU healthcare industry

HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and Versatile Point-of-Care Diagnostics

 

List of calls for applications that open on June 3, 2027, and close on September 22, 2027:

Destination – Developing and using new tools, technologies, and digital solutions for a healthy society

HORIZON-HLTH-2027-03-TOOL-02: Advancing the bioprinting of living cells for regenerative medicine

HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for Integrated Clinical Decision Support in Prevention and Diagnosis

HORIZON-HLTH-2027-03-TOOL-08: Toward Artificial General Intelligence (AGI) for Healthcare

 

**If you’re interested in any of our job openings or need more information, please don’t hesitate to contact us.

Requirements:

These calls for proposals are aimed at multidisciplinary European consortia. Unless otherwise specified in the specific conditions of the call, only legal entities that form a consortium will be eligible to participate in the actions, provided that the consortium includes, as beneficiaries, three legal entities that are independent of one another, each established in a different country, in accordance with the following criteria:

  • at least one independent legal entity established in a Member State; and

  • at least two other independent legal entities, each established in different Member States or Associated Countries.

Legal entities established in Russia, Belarus, or in territories of Ukraine not controlled by the government are not eligible.

How to apply

Applications consist of two sections:

-Part A (to be completed online) contains administrative information related to the consortium, the budget, and specific details of the call for proposals.

-Part B (a template downloaded from the Commission’s website must be completed) contains the scientific and technical aspects of the project.